Jacobs Receives GlaxoSmithKline Contract in England.PASADENA, Calif. -- Jacobs Engineering Group Jacobs Engineering Group Inc. (NYSE: JEC), a publicly traded company with annual revenues approaching $7 billion, provides professional technical services. Headquartered in Pasadena, CA, Jacobs offers support to industrial, commercial, and government clients across multiple Inc. (NYSE NYSE See: New York Stock Exchange :JEC) announced today that a subsidiary company received a contract from GlaxoSmithKline (GSK GSK GlaxoSmithKline plc (pharmaceutical company) GSK Glycogen Synthase Kinase GSK Gruppentraining Sozialer Kompetenzen (Germany) GSK Greenland Shark (FAO fish species code) ) to provide engineering, procurement The fancy word for "purchasing." The procurement department within an organization manages all the major purchases. , construction management, and validation services for a major upgrade to GSK's pilot plant manufacturing facilities at Tonbridge, Kent, England. Once completed, these facilities will support a growing program of new products introduced by GSK and will provide a high-quality facility consistent with industry best practices and standards. The upgrade will be carried out with minimum disruption to ongoing operations. This award follows Jacobs' successful completion of feasibility, conceptual, and scheme design phases of the project. In making the announcement, Jacobs Group Vice President Phil Stassi stated, "We are delighted to continue the close working relationship developed with the GlaxoSmithKline team and see the project through to completion. Through our shared values, we offer a working relationship built on established trust, accountability, teamwork, and quality of service. The achievement of GlaxoSmithKline's project objectives is our mutual focus." Jacobs, with over 35,000 employees and revenues approaching $5.0 billion, provides technical, professional, and construction services globally. Any statements made in this release that are not based on historical fact are forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. . Any forward-looking statements made in this release represent management's best judgement as to what may occur in the future. However, Jacobs' actual outcome and results are not guaranteed and are subject to certain risks, uncertainties and assumptions ("Future Factors"), and may differ materially from what is expressed. For a description of Future Factors that could cause actual results to differ materially from such forward-looking statements, see the discussion under the section "Forward-Looking Statements" included in Item 7 - Management's Discussion and Analysis Management's discussion and analysis (MD&A) A report from management to shareholders that accompanies the firm's financial statements in the annual report. It explains the period's financial results and enables management to discuss topics that may not be apparent in the financial of Financial Condition and Results of Operations contained in the Company's 2004 Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. . |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion